CAS ID: | 119141-88-7 |
Molecular Formula: | C17H19N3O3S |
Molecular Weight: | 345.4 g/mol |
Monoisotopic Mass: | 345.1147 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | ESOMEPRAZOLE STRONTIUM | EMOZUL | H199/18 SODIUM | NEXIUM IV | VENTRA | H199/18 MAGNESIUM TRIHYDRATE | ESOMEPRAZOLE POTASSIUM | ESOMEPRAZOLE | FM0F67 | NEXIUM 24HR | NEXIUM | NEXIUM CONTROL | ESOMEPRAZOLE SODIUM | NEXIUM I.V. | ESOMEPRAZOLE MAGNESIUM |
Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
ClinicalTrial ID | NCT01983774 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Terminated |
First Received | November 14, 2013 | Last Verified | April 14, 2015 |
Sponsor | Columbia University |
PubChem: | 9568614 |
ChEMBL: | CHEMBL1201320 |